MP:0000274 | enlarged heart | "increase over normal size of the heart" [J:29971] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0000613 | abnormal salivary gland morphology | "malformed saliva-secreting glands of the oral cavity" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:63764] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0000688 | lymphoid hyperplasia | "increased cell number in lymphatic tissues" [J:62478] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0000689 | abnormal spleen morphology | "atypical structure of the organ that functions to filter blood and to store red corpuscles and platelets" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:27463] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0000691 | enlarged spleen | "increased spleen size" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0000702 | enlarged lymph nodes | "lymph nodes of increased size" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0001489 | decreased startle reflex | "greater threshold or less severe reflex response to variable stimuli, often auditory; usually measured by amplitude of whole body flinch" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator, What s Wrong With My Mouse?:ISBN 0-471-31639-3] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0002059 | abnormal seminal gland morphology | "anomalous structure of one of the two folded, sac shaped, glands that is a diverticulum of the ductus deferens " [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0002644 | decreased circulating triglyceride level | "lower than normal concentration of triacylglycerols in the blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0002727 | decreased circulating insulin level | "less than normal levels of insulin in the blood" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, dlb:Donna Burkart , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0002834 | decreased heart weight | "less than average weight of the heart compared to the average for a particular strain" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0003009 | abnormal cytokine secretion | "impairment or increase of the cellular release of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells " [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, smb:Susan M. Bello , Mouse Genome Informatics Curator] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0005093 | impaired B cell proliferation | "absent or reduced ability of B cells to grow and divide in response to stimuli " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0005292 | improved glucose tolerance | "better than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin sensitivity; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0005419 | hypoalbuminemia | "blood albumin concentration below the normal range" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0005635 | decreased circulating bilirubin level | "less thant the normal concentration in the blood of this yellow heme breakdown product" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, RGD:Rat Genome Database submission] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|
MP:0008463 | abnormal peripheral lymph node morphology | "any structural anomaly of the lymph nodes located outside the thoracic and abdominal cavities, such as the submandibular, prescapular, axillary, inguinal and popliteal lymph nodes" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0008554 | decreased circulating tumor necrosis factor level | "reduction in the amount in the blood of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0008563 | decreased interferon-alpha secretion | "increase in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0008576 | decreased circulating interferon-beta level | "reduction in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0008597 | decreased circulating interleukin-6 level | "reduction in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0008648 | decreased circulating interleukin-12b level | "reduction in the amount in the blood of the p40 cytokine subunit that is a component of both interleukin-12 and interleukin-23" [MESH:D12.644.276.374.465.512.500] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0008661 | decreased interleukin-10 secretion | "reduction in the production or release of a cytokine produced by a variety of cell types, including T-cells, monocytes, dendritic cells and epithelial cells that exerts a variety of effects on immunoregulation and inflammation" [MESH:D12.644.276.374.465.510] |
Show
Allelic Composition: a/a,Mregdsu/Mregdsu,Hps6ru/Hps6ru Genetic Background: involves: C57BL/6J
|
MP:0008664 | decreased interleukin-12 secretion | "reduction in the production or release of a heterodimeric cytokine that plays a role in innate and adaptive immune responses; it is produced by dendritic cells, macrophages and a variety of other immune cells and plays a role in the stimulation of interferon-gamma production by T-cells and natural killer cells" [MESH:D12.644.276.374.465.512] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
Allelic Composition: Peli1tm1.1Arte/Peli1tm1.1Arte Genetic Background: involves: C57BL/6N
|
MP:0008706 | decreased interleukin-6 secretion | "reduction in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Peli1tm1.1Arte/Peli1tm1.1Arte Genetic Background: involves: C57BL/6N
|
MP:0008734 | decreased susceptibility to endotoxin shock | "less than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0008782 | increased B cell apoptosis | "increase in the timing or the number of B cells undergoing programmed cell death" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0009767 | decreased sensitivity to xenobiotic induced morbidity/mortality | "increase in the amount of a foreign compound required to cause death or diseased state" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Map3k4tm1Flv/Map3k4+,X/SryAKR/J Genetic Background: B6.Cg-Map3k4tm1Flv Chr YAKR
|
MP:0010831 | partial lethality | "the appearance of lower than Mendelian ratios of offspring of a given genotype due to death of some, but not all of the organisms" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Peli1tm1.1Arte/Peli1tm1.1Arte Genetic Background: involves: C57BL/6N
|
MP:0011110 | partial preweaning lethality | "the appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms between fertilization and weaning age (Mus: approximately 3-4 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Pcsk5tm1b(KOMP)Mbp/Pcsk5tm1b(KOMP)Mbp Genetic Background: C57BL/6N-Pcsk5tm1b(KOMP)Mbp/J
|